226 filings
Page 5 of 12
F-3
61svd4d hc
10 Nov 21
Shelf registration (foreign)
5:23pm
6-K
tb5c23ucdbxx
4 Nov 21
Index to Unaudited Condensed Consolidated Financial Statements
7:21am
6-K
hmc g1if60vl01aq
29 Oct 21
ObsEva Announces Management Change
5:24pm
6-K/A
400s7j
13 Oct 21
ObsEva Announces Relationship with Syneos Health to Commercialize Linzagolix
5:24pm
6-K
bcdg 4xkfe82xf
13 Oct 21
ObsEva Announces Relationship with Syneos Health to Commercialize Linzagolix
9:27am
6-K
pw9q6hjv fw
5 Aug 21
Index to Unaudited Condensed Consolidated Financial Statements
6:04am
6-K
0h8lrxgf
27 Jul 21
Current report (foreign)
6:12am
6-K
aikkze5h5a2f4t60u
1 Jun 21
ObsEva SA Announces that Shareholders Approved all Board Proposals at its
6:30am
6-K
ij2yawbn6qq 8oflz
25 May 21
ObsEva Announces Proposed Changes to the Composition of its
5:22pm
6-K
2kajpy 0r
20 May 21
ObsEva Announces Final Results from the Phase 3 PRIMROSE Program of
6:30am
6-K
wtb3ts1pognclgbwc49o
6 May 21
ObsEva appoints Clive Bertram as Chief Commercial Officer
6:05am
6-K
p42pj
6 May 21
Index to Unaudited Condensed Consolidated Financial Statements
6:03am
6-K
l7t00 j8g0xrxee1
22 Apr 21
ObsEva Annual General Meeting 2021
6:31am
6-K
okqv62s l0gz5h3
31 Mar 21
Current report (foreign)
7:15am
6-K
odhi9f0
5 Mar 21
Current report (foreign)
8:15am
424B5
1ve09krilldq3dqyhh8
5 Mar 21
Prospectus supplement for primary offering
7:55am
6-K
gg22e3ap8gccpzx0g
5 Mar 21
ObsEva Announces Year End 2020 Financial Results
7:21am
6-K
57oh4 utde
17 Feb 21
ObsEva to Present at the SVB Leerink 10th Annual Global Healthcare Conference
6:04am
6-K
w55c9vv 1xjwndv
11 Feb 21
ObsEva to Increase Issued Share Capital by Creating Additional Treasury Shares
6:08am